Robert H Shoemaker

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Childhood Cancer

Angiotensin Converting Enzyme

Top Venues

Cancer prevention research (Philadelphia, Pa.)

Cancer immunology research

EMBO molecular medicine

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Shizuko Sei, Sudhir Srivastava, Halonna R Kelly, Mark Steven Miller, Wolfgang W Leitner, Robert H Shoemaker, Eva Szabo, Philip E Castle
NCI Resources for Cancer Immunoprevention Research. Cancer immunology research 12 (4) (2024)
Shizuko Sei, Sudhir Srivastava, Halonna R Kelly, Mark Steven Miller, Wolfgang W Leitner, Robert H Shoemaker, Eva Szabo, Philip E Castle
NCI Resources for Cancer Immunoprevention Research. Cancer immunology research 12 (4) (2024)
Shizuko Sei, Sudhir Srivastava, Halonna R Kelly, Mark Steven Miller, Wolfgang W Leitner, Robert H Shoemaker, Eva Szabo, Philip E Castle
NCI Resources for Cancer Immunoprevention Research. Cancer immunology research 12 (4) (2024)
Shizuko Sei, Sudhir Srivastava, Halonna R Kelly, Mark Steven Miller, Wolfgang W Leitner, Robert H Shoemaker, Eva Szabo, Philip E Castle
NCI Resources for Cancer Immunoprevention Research. Cancer immunology research 12 (4) (2024)
Sharon A Ross, Nancy J Emenaker, Amit Kumar, Gabriela Riscuta, Kajal Biswas, Shanker Gupta, Altaf Mohammed, Robert H Shoemaker
Green Cancer Prevention and Beyond. Cancer prevention research (Philadelphia, Pa.) 17 (3) (2024)
Sharon A Ross, Nancy J Emenaker, Amit Kumar, Gabriela Riscuta, Kajal Biswas, Shanker Gupta, Altaf Mohammed, Robert H Shoemaker
Green Cancer Prevention and Beyond. Cancer prevention research (Philadelphia, Pa.) 17 (3) (2024)
Sharon A Ross, Nancy J Emenaker, Amit Kumar, Gabriela Riscuta, Kajal Biswas, Shanker Gupta, Altaf Mohammed, Robert H Shoemaker
Green Cancer Prevention and Beyond. Cancer prevention research (Philadelphia, Pa.) (2024)
Shizuko Sei, Sudhir Srivastava, Halonna R Kelly, Mark Steven Miller, Wolfgang W Leitner, Robert H Shoemaker, Eva Szabo, Philip E Castle
NCI Resources for Cancer Immunoprevention Research. Cancer immunology research (2024)
Sang Beom Lee, Jing Pan, Donghai Xiong, Katie Palen, Bryon Johnson, Ronald A Lubet, Robert H Shoemaker, Jeffrey E Green, Romaine Ingrid Fernando, Shizuko Sei, Ming You, Yian Wang
Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention. NPJ precision oncology 7 (1) (2023)
Vanessa M Monteil, Brett Eaton, Elena Postnikova, Michael Murphy, Benedict Braunsfeld, Ian Crozier, Franz Kricek, Janine Niederhöfer, Alice Schwarzböck, Helene Breid, Stéphanie Devignot, Jonas Klingström, Charlotte Thålin, Max J Kellner, Wanda Christ, Sebastian Havervall, Stefan Mereiter, Sylvia Knapp, Anna Sanchez Jimenez, Agnes Bugajska-Schretter, Alexander Dohnal, Christine Ruf, Romana Gugenberger, Astrid Hagelkruys, Nuria Montserrat, Ivona Kozieradzki, Omar Hasan Ali, Johannes Stadlmann, Michael R Holbrook, Connie Schmaljohn, Chris Oostenbrink, Robert H Shoemaker, Ali Mirazimi, Gerald Wirnsberger, Josef M Penninger
Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants. EMBO molecular medicine 14 (8) (2022)
Altaf Mohammed, Robert H Shoemaker
Targeting the Leukotriene Pathway for Colon Cancer Interception. Cancer prevention research (Philadelphia, Pa.) 15 (10) (2022)
Altaf Mohammed, Robert H Shoemaker, Shizuko Sei
Cancer Immunoprevention: Challenges and Potential Opportunities for Use of Immune Checkpoint Inhibitors. Cancer prevention research (Philadelphia, Pa.) 13 (11) (2020)